loadpatents
name:-0.01484489440918
name:-0.015555858612061
name:-0.0063469409942627
Romo; Daniel Patent Filings

Romo; Daniel

Patent Applications and Registrations

Patent applications and USPTO patent grants for Romo; Daniel.The latest application filed is for "gracilin a and congeners as immunosuppressive and neuroprotective agents".

Company Profile
6.13.13
  • Romo; Daniel - Waco TX
  • Romo; Daniel - College Station TX
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Gracilin A and congeners as immunosuppressive and neuroprotective agents
Grant 11,066,379 - Romo , et al. July 20, 2
2021-07-20
Beta-amino pateamine a derivatives and methods for treating chronic lymphocytic leukemia
Grant 10,889,596 - Romo , et al. January 12, 2
2021-01-12
Gracilin A And Congeners As Immunosuppressive And Neuroprotective Agents
App 20210002245 - Romo; Daniel ;   et al.
2021-01-07
Alpha-amino pateamine A derivatives and methods for treating chronic lymphocytic leukemia
Grant 10,870,662 - Romo , et al. December 22, 2
2020-12-22
Alpha-amino Pateamine A Derivatives And Methods For Treating Chronic Lymphocytic Leukemia
App 20190382417 - Romo; Daniel ;   et al.
2019-12-19
Alpha-amino pateamine A derivatives and methods for treating chronic lymphocytic leukemia
Grant 10,407,444 - Romo , et al. Sept
2019-09-10
Beta-amino Pateamine A Derivatives And Methods For Treating Chronic Lymphocytic Leukemia
App 20190177339 - Romo; Daniel ;   et al.
2019-06-13
Alpha-amino Pateamine A Derivatives And Methods For Treating Chronic Lymphocytic Leukemia
App 20180118764 - Romo; Daniel ;   et al.
2018-05-03
Potent immunosuppressive agents, derivatives and uses
Grant 8,841,285 - Romo , et al. September 23, 2
2014-09-23
Beta-lactone compounds
Grant 8,258,321 - Smith , et al. September 4, 2
2012-09-04
Method for the asymmetric synthesis of beta-lactone compounds
Grant 8,124,794 - Smith , et al. February 28, 2
2012-02-28
Belactosin derivatives as therapeutic agents/biological probes and their synthesis
Grant 8,119,653 - Romo , et al. February 21, 2
2012-02-21
Cyclic-fused beta-lactones and their synthesis
Grant 8,088,923 - Romo , et al. January 3, 2
2012-01-03
Method For Determination Of Marinobufagenin Levels And Compounds Employable In Such Method
App 20110207154 - PUSCHETT; JULES B. ;   et al.
2011-08-25
Potent Immunosuppressive Agents, Derivatives And Uses
App 20110053994 - Romo; Daniel ;   et al.
2011-03-03
Novel Method For The Asymmetric Synthesis Of Beta-lactone Compounds
App 20100173982 - Smith; Jeffrey W. ;   et al.
2010-07-08
Anticancer agents and use
Grant 7,737,134 - Romo , et al. June 15, 2
2010-06-15
Method for the asymmetric synthesis of beta-lactone compounds
Grant 7,728,153 - Smith , et al. June 1, 2
2010-06-01
Beta-lactone Compounds
App 20090124681 - Smith; Jeffrey W. ;   et al.
2009-05-14
Cyclic-fused Beta-lactones And Their Synthesis
App 20090062547 - Romo; Daniel ;   et al.
2009-03-05
Novel Belactosin Derivatives As Therapeutic Agents/biological Probes And Their Synthesis
App 20090042922 - Romo; Daniel ;   et al.
2009-02-12
Potent immunosuppressive agents derivatives and use
App 20070149581 - Romo; Daniel ;   et al.
2007-06-28
Potent, simplified derivatives of pateamine A
Grant 7,230,021 - Romo , et al. June 12, 2
2007-06-12
Novel method for the asymmetric synthesis of beta-lactone compounds
App 20060258620 - Smith; Jeffrey W. ;   et al.
2006-11-16
Potent, simplified derivatives of immunosuppressive agents
App 20030216436 - Romo, Daniel ;   et al.
2003-11-20
Company Registrations

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed